These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30075600)

  • 41. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses.
    Yuen PM; Yu KM; Yip SK; Lau WC; Rogers MS; Chang A
    Am J Obstet Gynecol; 1997 Jul; 177(1):109-14. PubMed ID: 9240592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.
    Terlikowska KM; Dobrzycka B; Witkowska AM; Mackowiak-Matejczyk B; Sledziewski TK; Kinalski M; Terlikowski SJ
    J Ovarian Res; 2016 Jul; 9(1):43. PubMed ID: 27436085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selected adnexal cystic masses in postmenopausal women can be safely managed by laparoscopy.
    Lee JW; Kim CJ; Lee JE; Lee SJ; Kim BG; Lee JH; Bae DS; Park CS
    J Korean Med Sci; 2005 Jun; 20(3):468-72. PubMed ID: 15953871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficiency of ultrasonography in the diagnosis of dermoid cysts.
    Ekici E; Soysal M; Kara S; Dogan M; Gokmen O
    Zentralbl Gynakol; 1996; 118(3):136-41. PubMed ID: 8900602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
    Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
    Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of the echo pattern classification of ovarian tumors 2000 in conjunction with transvaginal ultrasonography for diagnosis of ovarian masses.
    Tajima A; Suzuki C; Kikuchi I; Kasahara H; Koizumi A; Nojima M; Yoshida K
    J Med Ultrason (2001); 2016 Apr; 43(2):249-55. PubMed ID: 26660908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?
    Yanaranop M; Anakrat V; Siricharoenthai S; Nakrangsee S; Thinkhamrop B
    Gynecol Obstet Invest; 2017; 82(1):47-53. PubMed ID: 27197526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The experience of our Clinic in laparoscopy for adnexal masses and the correlation between ultrasound findings and pathological results.
    Pleş L; Sima RM; Burnei A; Albu DF; Bujor MA; Conci S; Teodorescu V; Edu A
    Rom J Morphol Embryol; 2016; 57(4):1337-1341. PubMed ID: 28174801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
    Varras M
    Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of false negative results of subjective ultrasonography assessment of adnexal masses.
    Moszynski R; Szpurek D; Szubert S; Sajdak S
    Ginekol Pol; 2013 Feb; 84(2):102-7. PubMed ID: 23668055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses.
    Aslan K; Onan MA; Yilmaz C; Bukan N; Erdem M
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101713. PubMed ID: 32084612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor markers and transvaginal ultrasonography in the diagnosis of endometrioma.
    Guerriero S; Ajossa S; Paoletti AM; Mais V; Angiolucci M; Melis GB
    Obstet Gynecol; 1996 Sep; 88(3):403-7. PubMed ID: 8752248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ovarian cysts: strategy and prognosis].
    Querleu D; Parmentier D; Chevallier L
    Contracept Fertil Sex; 1993 Feb; 21(2):167-72. PubMed ID: 7951609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The characterization of common ovarian cysts in premenopausal women.
    Jermy K; Luise C; Bourne T
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):140-4. PubMed ID: 11251923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraoperative Rupture of Ovarian Dermoid Cysts in the Pediatric and Adolescent Population: Should This Change Your Surgical Management?
    Childress KJ; Santos XM; Perez-Milicua G; Hakim J; Adeyemi-Fowode O; Bercaw-Pratt JL; Dietrich JE
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):636-640. PubMed ID: 28336475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.
    Han KH; Park NH; Kim JJ; Kim S; Kim HS; Lee M; Song YS
    J Gynecol Oncol; 2019 Nov; 30(6):e83. PubMed ID: 31576682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age.
    Kondalsamy-Chennakesavan S; Hackethal A; Bowtell D; ; Obermair A
    Gynecol Oncol; 2013 Jun; 129(3):467-71. PubMed ID: 23500084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.